Clinical Research Directory
Browse clinical research sites, groups, and studies.
Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Summary
Pancreatic head cancer represents one of the most frequent malignancies with an incidence of about 13500 new cases each year. The primary objective of the study is to test whether there are bacterial species associated with increased risk of complications in patients with peri-ampullary neoplasia undergoing DCP.
Official title: Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer (MIcRobiome Analysis in Patients UnderGoing PancrEatico-duodenectomy for Pancreatic Cancer MIRAGE Study)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2022-07-11
Completion Date
2025-07-01
Last Updated
2025-01-30
Healthy Volunteers
No
Conditions
Interventions
Microbiota analysis
Upon acquisition of informed consent, fecal, digiunal mucosa, biliary and pancreatic fluid samples will be collected for microbiota analysis
Locations (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, BO, Italy